Famon Awal Bros Sedaya
PT Famon Awal Bros Sedaya Tbk operates a network of hospitals in Indonesia. The company offers health services relating to heart and blood vessels, trauma, oncology, urology, mother and childcare, eye, cancer, gastroenteric hepatology, and stroke care, as well as operates orthaopaedic and sports center, beauty care services. It also offers clinical laboratory service, homecare, and medical evacua… Read more
Famon Awal Bros Sedaya (PRAY) - Net Assets
Latest net assets as of June 2025: Rp3.24 Trillion IDR
Based on the latest financial reports, Famon Awal Bros Sedaya (PRAY) has net assets worth Rp3.24 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp5.38 Trillion) and total liabilities (Rp2.14 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp3.24 Trillion |
| % of Total Assets | 60.17% |
| Annual Growth Rate | 20.07% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 15.67 |
Famon Awal Bros Sedaya - Net Assets Trend (2020–2024)
This chart illustrates how Famon Awal Bros Sedaya's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Famon Awal Bros Sedaya (2020–2024)
The table below shows the annual net assets of Famon Awal Bros Sedaya from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp3.13 Trillion | +6.80% |
| 2023-12-31 | Rp2.93 Trillion | +8.41% |
| 2022-12-31 | Rp2.71 Trillion | +45.86% |
| 2021-12-31 | Rp1.86 Trillion | +23.08% |
| 2020-12-31 | Rp1.51 Trillion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Famon Awal Bros Sedaya's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 83.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp1.37 Trillion | 45.64% |
| Common Stock | Rp139.59 Billion | 4.64% |
| Other Comprehensive Income | Rp87.79 Billion | 2.92% |
| Other Components | Rp1.41 Trillion | 46.80% |
| Total Equity | Rp3.01 Trillion | 100.00% |
Famon Awal Bros Sedaya Competitors by Market Cap
The table below lists competitors of Famon Awal Bros Sedaya ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RCF ACQ.CORP.CL.A -0001
F:GY0
|
$52.91 Million |
|
Scope Fluidics SA
WAR:SCP
|
$52.93 Million |
|
NSL Foods Public Company Limited
BK:NSL
|
$52.95 Million |
|
Eagle High Plantations Tbk
JK:BWPT
|
$52.97 Million |
|
Hi Sun Technology (China) Limited
PINK:HISNF
|
$52.90 Million |
|
Zomedica Pharmaceuticals Corp
NYSE MKT:ZOM
|
$52.89 Million |
|
Topps Tiles Plc
PINK:TPTJF
|
$52.89 Million |
|
FTC Solar Inc
NASDAQ:FTCI
|
$52.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Famon Awal Bros Sedaya's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,798,525,000,000 to 3,007,262,000,000, a change of 208,737,000,000 (7.5%).
- Net income of 201,443,000,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 50,000,000,000.
- Other factors decreased equity by 42,706,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp201.44 Billion | +6.7% |
| Other Comprehensive Income | Rp50.00 Billion | +1.66% |
| Other Changes | Rp-42.71 Billion | -1.42% |
| Total Change | Rp- | 7.46% |
Book Value vs Market Value Analysis
This analysis compares Famon Awal Bros Sedaya's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.48x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.07x to 3.48x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | Rp106.11 | Rp750.00 | x |
| 2021-12-31 | Rp123.93 | Rp750.00 | x |
| 2022-12-31 | Rp185.40 | Rp750.00 | x |
| 2023-12-31 | Rp200.48 | Rp750.00 | x |
| 2024-12-31 | Rp215.43 | Rp750.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Famon Awal Bros Sedaya utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.70%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.58%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.69x
- Recent ROE (6.70%) is below the historical average (11.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 20.05% | 21.10% | 0.56x | 1.71x | Rp141.48 Billion |
| 2021 | 18.84% | 17.85% | 0.58x | 1.81x | Rp152.96 Billion |
| 2022 | 2.41% | 4.10% | 0.38x | 1.53x | Rp-196.31 Billion |
| 2023 | 7.75% | 11.80% | 0.39x | 1.68x | Rp-62.88 Billion |
| 2024 | 6.70% | 9.58% | 0.41x | 1.69x | Rp-99.28 Billion |
Industry Comparison
This section compares Famon Awal Bros Sedaya's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,793,226,130,924
- Average return on equity (ROE) among peers: 27.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Famon Awal Bros Sedaya (PRAY) | Rp3.24 Trillion | 20.05% | 0.66x | $52.90 Million |
| Bundamedik Tbk PT (BMHS) | $665.59 Billion | 4.71% | 1.10x | $23.76 Million |
| Metro Healthcare Indonesia (CARE) | $3.30 Trillion | 0.18% | 0.28x | $411.41 Million |
| Medikaloka Hermina PT (HEAL) | $2.37 Trillion | 5.25% | 0.76x | $810.80 Million |
| Lippo Karawaci Tbk (LPKR) | $23.57 Trillion | -40.88% | 1.20x | $179.43 Million |
| Mitra Keluarga Karyasehat Tbk PT (MIKA) | $3.28 Trillion | 17.29% | 0.13x | $602.27 Million |
| PT Murni Sadar Tbk (MTMH) | $50.49 Billion | 4.95% | 14.96x | $27.98 Million |
| Royal Prima PT (PRIM) | $722.89 Million | 252.77% | 36.50x | $3.23 Million |
| PT Charlie Hospital Semarang Tbk (RSCH) | $150.46 Billion | -0.74% | 0.03x | $11.66 Million |
| Kedoya Adyaraya Tbk PT (RSGK) | $751.16 Billion | 3.35% | 0.10x | $3.08 Million |